PAPER Cotelli M, Manenti R, Brambilla M, Balconi M
SEARCH RESULTS
330026 RESULTS
PAPER Balouch S, Rusted JM
Error-monitoring in an everyday task in people with Alzheimer-type dementia: observations over five years of performance decline.
J Clin Exp Neuropsychol. 2014;36(7):773-86. Epub 2014 Aug 13 PubMed: 25116037PAPER Schoemaker D, Gauthier S, Pruessner JC
Recollection and familiarity in aging individuals with mild cognitive impairment and Alzheimer's disease: a literature review.
Neuropsychol Rev. 2014 Sep;24(3):313-31. Epub 2014 Aug 13 PubMed: 25115809PAPER Xue X, Wang LR, Sato Y, Jiang Y, Berg M, Yang DS, Nixon RA, Liang XJ
Single-walled carbon nanotubes alleviate autophagic/lysosomal defects in primary glia from a mouse model of Alzheimer's disease.
Nano Lett. 2014 Sep 10;14(9):5110-7. Epub 2014 Aug 21 PubMed: 25115676PAPER Chauhan K, Datta A, Adhikari A, Chuttani K, Kumar Singh A, Mishra AK
(68)Ga based probe for Alzheimer's disease: synthesis and preclinical evaluation of homodimeric chalcone in β-amyloid imaging.
Org Biomol Chem. 2014 Oct 7;12(37):7328-37. PubMed: 25115649PAPER Puli L, Tanila H, Relkin N
Intravenous immunoglobulins for Alzheimer's disease.
Curr Alzheimer Res. 2014;11(7):626-36. PubMed: 25115546PAPER Gong B, Levine S, Barnum SR, Pasinetti GM
Role of complement systems in IVIG mediated attenuation of cognitive deterioration in Alzheimer's disease.
Curr Alzheimer Res. 2014;11(7):637-44. PubMed: 25115545PAPER Lahiri DK, Ray B
Intravenous immunoglobulin treatment preserves and protects primary rat hippocampal neurons and primary human brain cultures against oxidative insults.
Curr Alzheimer Res. 2014;11(7):645-54. PubMed: 25115544PAPER Joly-Amado A, Brownlow M, Pierce J, Ravipati A, Showalter E, Li Q, Gordon MN, Morgan D
Intraventricular human immunoglobulin distributes extensively but fails to modify amyloid in a mouse model of amyloid deposition.
Curr Alzheimer Res. 2014;11(7):664-71. PubMed: 25115543PAPER Wang J, Zhang Y, Xu H, Zhu S, Wang H, He J, Zhang H, Guo H, Kong J, Huang Q, Li XM
Fluoxetine improves behavioral performance by suppressing the production of soluble β-amyloid in APP/PS1 mice.
Curr Alzheimer Res. 2014;11(7):672-80. PubMed: 25115542PAPER Zilkens RR, Bruce DG, Duke J, Spilsbury K, Semmens JB
Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65-84 years): a population based case-control study.
Curr Alzheimer Res. 2014;11(7):681-93. PubMed: 25115541PAPER Iyer AM, van Scheppingen J, Milenkovic I, Anink JJ, Lim D, Genazzani AA, Adle-Biassette H, Kovacs GG, Aronica E
Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.
Curr Alzheimer Res. 2014;11(7):694-705. PubMed: 25115540PAPER Zhou R, Zhou H, Rui L, Xu J
Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer's disease.
Curr Alzheimer Res. 2014;11(7):706-13. PubMed: 25115539PAPER Edwards SR, Hamlin AS, Marks N, Coulson EJ, Smith MT
Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
Clin Exp Pharmacol Physiol. 2014 Oct;41(10):798-806. PubMed: 25115283PAPER Furumiya J, Hashimoto Y
A Descriptive Study of Elderly Patients With Dementia Who Died Wandering Outdoors in Kochi Prefecture, Japan.
Am J Alzheimers Dis Other Demen. 2014 Aug 12; PubMed: 25115170Current Filters
No filters selected